Published date: 16 January 2023
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Vaccines - 33651600
Design and execution of research and development - 73300000
Location of contract
SW1H 0EU
Value of contract
£1
Procurement reference
CF-1275900D0O000000rwimUAA
Published date
16 January 2023
Closing date
19 December 2022
Closing time
12am
Contract start date
20 December 2022
Contract end date
19 December 2032
Contract type
Supply contract
Procedure type
Other
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA vaccines and therapeutics within the UK.
Award information
Awarded date
20 December 2022
Contract start date
20 December 2022
Contract end date
19 December 2032
Total value of contract
£1
This contract was awarded to 1 supplier.
MODERNA BIOTECH UK LIMITED
Address
54 Portland Place, London, W1B 1DY W1B 1DY
Reference
None
Supplier is SME?
Yes
About the buyer
Contact name
Procurement Operations
Address
39 Victoria Street
London
SW1H 0EU
GB
Share this notice
Closing: 19 December 2022, 12am